 Jeremy Prager
Concepts (391)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trachea | 13 | 2022 | 231 | 2.910 |
Why?
| | Otolaryngology | 7 | 2022 | 88 | 1.970 |
Why?
| | Laryngoscopy | 8 | 2024 | 100 | 1.710 |
Why?
| | Respiratory Tract Diseases | 4 | 2019 | 149 | 1.640 |
Why?
| | Tracheal Stenosis | 6 | 2023 | 28 | 1.630 |
Why?
| | Tonsillectomy | 4 | 2021 | 82 | 1.500 |
Why?
| | Bronchoscopy | 12 | 2021 | 219 | 1.440 |
Why?
| | Larynx | 4 | 2024 | 60 | 1.280 |
Why?
| | Tracheomalacia | 4 | 2022 | 17 | 1.230 |
Why?
| | Correspondence as Topic | 3 | 2012 | 14 | 1.130 |
Why?
| | Deglutition Disorders | 4 | 2023 | 133 | 0.990 |
Why?
| | Laryngostenosis | 3 | 2023 | 47 | 0.980 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2018 | 103 | 0.950 |
Why?
| | Otitis Media | 7 | 2023 | 160 | 0.950 |
Why?
| | Airway Obstruction | 6 | 2021 | 154 | 0.880 |
Why?
| | Esophagoscopy | 4 | 2020 | 198 | 0.850 |
Why?
| | Efficiency, Organizational | 4 | 2019 | 134 | 0.830 |
Why?
| | Operating Rooms | 2 | 2015 | 117 | 0.810 |
Why?
| | Gastrointestinal Diseases | 3 | 2019 | 198 | 0.800 |
Why?
| | Child | 52 | 2024 | 20962 | 0.770 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 3 | 2021 | 37 | 0.760 |
Why?
| | Adenoidectomy | 4 | 2021 | 65 | 0.750 |
Why?
| | Otorhinolaryngologic Diseases | 2 | 2019 | 16 | 0.730 |
Why?
| | Polytetrafluoroethylene | 1 | 2021 | 24 | 0.730 |
Why?
| | Respiratory Sounds | 2 | 2018 | 118 | 0.700 |
Why?
| | Abscess | 1 | 2020 | 73 | 0.660 |
Why?
| | Congenital Abnormalities | 2 | 2024 | 76 | 0.660 |
Why?
| | Ancillary Services, Hospital | 1 | 2019 | 2 | 0.650 |
Why?
| | Internship and Residency | 4 | 2020 | 1058 | 0.650 |
Why?
| | Hematologic Neoplasms | 1 | 2021 | 141 | 0.650 |
Why?
| | Hospitals, Pediatric | 6 | 2020 | 517 | 0.630 |
Why?
| | Patient Care Team | 3 | 2019 | 603 | 0.630 |
Why?
| | Digestive System Diseases | 1 | 2019 | 26 | 0.620 |
Why?
| | Craniocerebral Trauma | 1 | 2020 | 151 | 0.610 |
Why?
| | Helicobacter Infections | 1 | 2018 | 29 | 0.610 |
Why?
| | Helicobacter pylori | 1 | 2018 | 38 | 0.600 |
Why?
| | Intubation, Intratracheal | 3 | 2015 | 248 | 0.580 |
Why?
| | Tracheal Neoplasms | 1 | 2018 | 9 | 0.580 |
Why?
| | Tracheostomy | 2 | 2019 | 129 | 0.570 |
Why?
| | Eosinophilic Esophagitis | 3 | 2019 | 318 | 0.570 |
Why?
| | Humans | 82 | 2024 | 129847 | 0.550 |
Why?
| | Paraganglioma | 1 | 2018 | 49 | 0.540 |
Why?
| | Quality Improvement | 3 | 2016 | 1112 | 0.520 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 250 | 0.500 |
Why?
| | Gastroesophageal Reflux | 4 | 2023 | 232 | 0.500 |
Why?
| | Clinical Competence | 4 | 2020 | 1020 | 0.490 |
Why?
| | Child, Preschool | 30 | 2024 | 10522 | 0.480 |
Why?
| | Tracheoesophageal Fistula | 3 | 2022 | 33 | 0.480 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2015 | 33 | 0.470 |
Why?
| | Patient Satisfaction | 2 | 2019 | 639 | 0.470 |
Why?
| | Infant | 22 | 2024 | 9018 | 0.470 |
Why?
| | Gastroenterology | 3 | 2023 | 177 | 0.470 |
Why?
| | Delphi Technique | 8 | 2024 | 227 | 0.450 |
Why?
| | Spinal Fractures | 1 | 2015 | 84 | 0.450 |
Why?
| | Phenol | 1 | 2014 | 19 | 0.450 |
Why?
| | Postoperative Complications | 6 | 2022 | 2481 | 0.450 |
Why?
| | Drug Labeling | 1 | 2014 | 41 | 0.450 |
Why?
| | Retrospective Studies | 23 | 2023 | 14553 | 0.440 |
Why?
| | Anti-Infective Agents, Local | 1 | 2014 | 41 | 0.440 |
Why?
| | Burns, Chemical | 1 | 2014 | 32 | 0.440 |
Why?
| | Male | 44 | 2024 | 63759 | 0.430 |
Why?
| | Medical Audit | 1 | 2014 | 74 | 0.430 |
Why?
| | Consensus | 7 | 2024 | 622 | 0.420 |
Why?
| | Chromosome Disorders | 1 | 2013 | 40 | 0.420 |
Why?
| | Thyroid Neoplasms | 3 | 2023 | 311 | 0.410 |
Why?
| | Career Choice | 2 | 2011 | 206 | 0.400 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 273 | 0.390 |
Why?
| | Abnormalities, Multiple | 1 | 2013 | 175 | 0.380 |
Why?
| | Sleep Apnea Syndromes | 1 | 2013 | 82 | 0.380 |
Why?
| | Student Dropouts | 1 | 2011 | 8 | 0.370 |
Why?
| | Female | 41 | 2024 | 68829 | 0.360 |
Why?
| | Writing | 1 | 2012 | 91 | 0.360 |
Why?
| | Job Description | 1 | 2010 | 14 | 0.350 |
Why?
| | Pharyngeal Diseases | 1 | 2010 | 15 | 0.350 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2012 | 175 | 0.350 |
Why?
| | Endoscopy, Gastrointestinal | 2 | 2024 | 219 | 0.350 |
Why?
| | Deafness | 1 | 2012 | 80 | 0.350 |
Why?
| | Pediatrics | 4 | 2019 | 1074 | 0.350 |
Why?
| | Education, Medical, Continuing | 1 | 2011 | 123 | 0.350 |
Why?
| | School Admission Criteria | 1 | 2010 | 23 | 0.340 |
Why?
| | Pulmonary Embolism | 1 | 2013 | 212 | 0.340 |
Why?
| | Cochlear Implantation | 1 | 2012 | 88 | 0.340 |
Why?
| | Bronchiectasis | 3 | 2020 | 110 | 0.340 |
Why?
| | Fucosyltransferases | 2 | 2022 | 32 | 0.340 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 593 | 0.330 |
Why?
| | Personnel Selection | 1 | 2010 | 70 | 0.330 |
Why?
| | Tracheotomy | 4 | 2019 | 22 | 0.320 |
Why?
| | Adolescent | 24 | 2024 | 20451 | 0.310 |
Why?
| | Palatine Tonsil | 2 | 2021 | 45 | 0.300 |
Why?
| | Microbiota | 5 | 2023 | 734 | 0.300 |
Why?
| | Infant, Newborn | 8 | 2023 | 5772 | 0.300 |
Why?
| | Thoracoscopy | 2 | 2019 | 54 | 0.300 |
Why?
| | Anesthesia | 2 | 2023 | 172 | 0.290 |
Why?
| | Esophageal Atresia | 2 | 2020 | 24 | 0.290 |
Why?
| | Hearing Loss, Conductive | 1 | 2007 | 25 | 0.280 |
Why?
| | Faculty, Medical | 1 | 2010 | 269 | 0.280 |
Why?
| | Craniosynostoses | 1 | 2007 | 39 | 0.280 |
Why?
| | Treatment Outcome | 9 | 2024 | 10241 | 0.260 |
Why?
| | Ear, Middle | 5 | 2023 | 91 | 0.260 |
Why?
| | Program Development | 2 | 2019 | 355 | 0.260 |
Why?
| | Deglutition | 2 | 2024 | 67 | 0.260 |
Why?
| | Surgeons | 2 | 2020 | 264 | 0.250 |
Why?
| | Down Syndrome | 2 | 2023 | 478 | 0.250 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1514 | 0.240 |
Why?
| | Tracheobronchomalacia | 2 | 2022 | 14 | 0.230 |
Why?
| | Biopsy | 3 | 2019 | 1089 | 0.230 |
Why?
| | Respiratory Tract Infections | 3 | 2021 | 376 | 0.230 |
Why?
| | Nasal Septal Perforation | 1 | 2024 | 4 | 0.230 |
Why?
| | Fascia | 1 | 2024 | 17 | 0.230 |
Why?
| | Sutures | 2 | 2021 | 53 | 0.220 |
Why?
| | Multiple Endocrine Neoplasia | 1 | 2023 | 5 | 0.210 |
Why?
| | Multiple Endocrine Neoplasia Type 2b | 1 | 2023 | 6 | 0.210 |
Why?
| | Multiple Endocrine Neoplasia Type 2a | 1 | 2023 | 9 | 0.210 |
Why?
| | Membrane Proteins | 2 | 2021 | 1119 | 0.210 |
Why?
| | Croup | 1 | 2023 | 26 | 0.200 |
Why?
| | Vocal Cord Dysfunction | 1 | 2022 | 10 | 0.200 |
Why?
| | Hypoparathyroidism | 1 | 2022 | 4 | 0.190 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2022 | 13 | 0.190 |
Why?
| | Colorado | 5 | 2020 | 4410 | 0.190 |
Why?
| | Laryngoscopes | 1 | 2022 | 35 | 0.190 |
Why?
| | Graves Disease | 1 | 2022 | 34 | 0.190 |
Why?
| | Constriction, Pathologic | 4 | 2023 | 234 | 0.190 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.180 |
Why?
| | Haemophilus Infections | 1 | 2022 | 40 | 0.180 |
Why?
| | Nasopharynx | 1 | 2022 | 69 | 0.180 |
Why?
| | Medicine | 1 | 2023 | 119 | 0.180 |
Why?
| | Acrocephalosyndactylia | 1 | 2021 | 8 | 0.180 |
Why?
| | Job Satisfaction | 1 | 2023 | 204 | 0.180 |
Why?
| | Nasal Obstruction | 1 | 2021 | 27 | 0.180 |
Why?
| | Nasal Septum | 1 | 2020 | 25 | 0.170 |
Why?
| | Plasminogen | 1 | 2020 | 30 | 0.170 |
Why?
| | Hematoma | 1 | 2020 | 53 | 0.170 |
Why?
| | Follow-Up Studies | 7 | 2019 | 4896 | 0.170 |
Why?
| | Mucolipidoses | 1 | 2020 | 7 | 0.170 |
Why?
| | Bevacizumab | 1 | 2021 | 128 | 0.170 |
Why?
| | Bone Marrow Transplantation | 4 | 1997 | 277 | 0.160 |
Why?
| | Respiratory Tract Fistula | 1 | 2019 | 7 | 0.160 |
Why?
| | Cutaneous Fistula | 1 | 2019 | 13 | 0.160 |
Why?
| | Tracheal Diseases | 1 | 2019 | 15 | 0.160 |
Why?
| | Cartilage | 1 | 2021 | 183 | 0.160 |
Why?
| | Arytenoid Cartilage | 1 | 2019 | 7 | 0.160 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 24 | 0.160 |
Why?
| | Angiogenesis Inhibitors | 1 | 2021 | 218 | 0.160 |
Why?
| | Registries | 2 | 2024 | 1903 | 0.160 |
Why?
| | Speech-Language Pathology | 1 | 2019 | 20 | 0.160 |
Why?
| | Young Adult | 9 | 2024 | 12467 | 0.150 |
Why?
| | Laryngomalacia | 1 | 2018 | 4 | 0.150 |
Why?
| | Papillomavirus Infections | 2 | 2021 | 297 | 0.150 |
Why?
| | Laryngoplasty | 1 | 2018 | 5 | 0.150 |
Why?
| | Chemoreceptor Cells | 1 | 2019 | 54 | 0.150 |
Why?
| | United States | 7 | 2019 | 13913 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2020 | 316 | 0.150 |
Why?
| | Airway Extubation | 1 | 2019 | 54 | 0.150 |
Why?
| | Models, Organizational | 1 | 2019 | 145 | 0.150 |
Why?
| | Pulmonary Medicine | 1 | 2019 | 80 | 0.150 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 187 | 0.150 |
Why?
| | Respiratory System | 1 | 2019 | 156 | 0.140 |
Why?
| | Vascular Diseases | 1 | 2020 | 240 | 0.140 |
Why?
| | Esophageal Mucosa | 1 | 2018 | 19 | 0.140 |
Why?
| | Respiration Disorders | 1 | 2018 | 72 | 0.140 |
Why?
| | Virtual Reality | 1 | 2019 | 53 | 0.140 |
Why?
| | Child Behavior | 1 | 2020 | 236 | 0.140 |
Why?
| | Severity of Illness Index | 4 | 2016 | 2739 | 0.140 |
Why?
| | Proton Pump Inhibitors | 1 | 2018 | 100 | 0.140 |
Why?
| | Pain, Postoperative | 1 | 2020 | 247 | 0.140 |
Why?
| | Carcinoma, Medullary | 1 | 2017 | 14 | 0.140 |
Why?
| | Reoperation | 2 | 2018 | 542 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 252 | 0.140 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2022 | 378 | 0.140 |
Why?
| | Burnout, Professional | 1 | 2023 | 411 | 0.130 |
Why?
| | Down-Regulation | 1 | 2019 | 631 | 0.130 |
Why?
| | Gastrostomy | 1 | 2018 | 109 | 0.130 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 569 | 0.130 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 778 | 0.130 |
Why?
| | Neuromuscular Nondepolarizing Agents | 1 | 2015 | 17 | 0.120 |
Why?
| | Androstanols | 1 | 2015 | 17 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 3 | 2021 | 2271 | 0.120 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2023 | 524 | 0.120 |
Why?
| | Anesthetics, Intravenous | 1 | 2015 | 46 | 0.120 |
Why?
| | Midazolam | 1 | 2015 | 55 | 0.120 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 5437 | 0.120 |
Why?
| | Clinical Audit | 1 | 2015 | 11 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 342 | 0.120 |
Why?
| | Time and Motion Studies | 1 | 2015 | 21 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 336 | 0.120 |
Why?
| | Mouth | 1 | 2015 | 84 | 0.120 |
Why?
| | Reproducibility of Results | 3 | 2024 | 3089 | 0.120 |
Why?
| | Fentanyl | 1 | 2015 | 81 | 0.120 |
Why?
| | Esophagus | 3 | 2024 | 251 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 3 | 2020 | 2511 | 0.120 |
Why?
| | Prognosis | 3 | 2018 | 3773 | 0.120 |
Why?
| | Program Evaluation | 1 | 2019 | 878 | 0.110 |
Why?
| | Survival Rate | 2 | 2018 | 1872 | 0.110 |
Why?
| | Respiratory Aspiration | 1 | 2014 | 31 | 0.110 |
Why?
| | Administration, Intranasal | 1 | 2014 | 84 | 0.110 |
Why?
| | Quality of Health Care | 1 | 2019 | 610 | 0.110 |
Why?
| | Pedigree | 3 | 2020 | 483 | 0.110 |
Why?
| | Iatrogenic Disease | 1 | 2014 | 60 | 0.110 |
Why?
| | Bronchogenic Cyst | 1 | 2013 | 6 | 0.110 |
Why?
| | Anesthetics, Local | 1 | 2014 | 79 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2018 | 509 | 0.110 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2013 | 69 | 0.110 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 127 | 0.110 |
Why?
| | Genetic Variation | 1 | 2018 | 937 | 0.110 |
Why?
| | Chromosome Deletion | 1 | 2013 | 103 | 0.110 |
Why?
| | Appointments and Schedules | 1 | 2014 | 85 | 0.100 |
Why?
| | Prospective Studies | 4 | 2024 | 7158 | 0.100 |
Why?
| | Radiography | 1 | 2015 | 800 | 0.100 |
Why?
| | Pharyngitis | 1 | 2013 | 25 | 0.100 |
Why?
| | Rhinitis | 1 | 2014 | 152 | 0.100 |
Why?
| | Tetanus Antitoxin | 1 | 1992 | 3 | 0.100 |
Why?
| | Tetanus Toxoid | 1 | 1992 | 37 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1686 | 0.100 |
Why?
| | Graft Rejection | 1 | 2016 | 598 | 0.100 |
Why?
| | Fatal Outcome | 1 | 2013 | 300 | 0.100 |
Why?
| | Academic Medical Centers | 1 | 2015 | 483 | 0.100 |
Why?
| | Immunization, Secondary | 1 | 1992 | 87 | 0.090 |
Why?
| | Sinusitis | 1 | 2014 | 211 | 0.090 |
Why?
| | Mutation | 2 | 2021 | 3706 | 0.090 |
Why?
| | Patient Safety | 1 | 2015 | 291 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1500 | 0.090 |
Why?
| | Time Factors | 3 | 2019 | 6550 | 0.090 |
Why?
| | Cytosine | 1 | 2011 | 49 | 0.090 |
Why?
| | Off-Label Use | 1 | 2011 | 51 | 0.090 |
Why?
| | Patient Readmission | 1 | 2016 | 668 | 0.090 |
Why?
| | Airway Management | 1 | 2011 | 46 | 0.090 |
Why?
| | Ear Ossicles | 1 | 2010 | 15 | 0.090 |
Why?
| | Organophosphonates | 1 | 2011 | 92 | 0.080 |
Why?
| | Endoscopy, Digestive System | 2 | 2024 | 123 | 0.080 |
Why?
| | Referral and Consultation | 1 | 2015 | 735 | 0.080 |
Why?
| | Teratoma | 1 | 2011 | 103 | 0.080 |
Why?
| | Asthma | 1 | 2023 | 2225 | 0.080 |
Why?
| | Professional Competence | 1 | 2010 | 96 | 0.080 |
Why?
| | Disclosure | 1 | 2010 | 110 | 0.080 |
Why?
| | Thyroidectomy | 2 | 2022 | 87 | 0.080 |
Why?
| | Hospitalization | 1 | 2018 | 2079 | 0.080 |
Why?
| | Patient Selection | 1 | 2012 | 660 | 0.080 |
Why?
| | Communication | 1 | 2015 | 847 | 0.080 |
Why?
| | Electronic Health Records | 1 | 2016 | 979 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 2 | 2018 | 3397 | 0.070 |
Why?
| | Middle Ear Ventilation | 1 | 2007 | 14 | 0.070 |
Why?
| | Audiometry | 1 | 2007 | 27 | 0.070 |
Why?
| | Prevalence | 2 | 2020 | 2564 | 0.070 |
Why?
| | Risk Factors | 3 | 2019 | 9801 | 0.070 |
Why?
| | Mice | 5 | 2022 | 16983 | 0.060 |
Why?
| | Antiviral Agents | 2 | 2011 | 719 | 0.060 |
Why?
| | Hematologic Diseases | 1 | 1986 | 61 | 0.060 |
Why?
| | Catheters, Indwelling | 1 | 1986 | 80 | 0.060 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 544 | 0.060 |
Why?
| | Pilot Projects | 1 | 2010 | 1597 | 0.060 |
Why?
| | Practice Patterns, Physicians' | 1 | 2014 | 1274 | 0.060 |
Why?
| | Temporal Muscle | 1 | 2024 | 3 | 0.060 |
Why?
| | Cadaver | 2 | 2019 | 308 | 0.060 |
Why?
| | Absorbable Implants | 1 | 2024 | 35 | 0.060 |
Why?
| | Video Recording | 1 | 2024 | 164 | 0.050 |
Why?
| | Polyesters | 1 | 2024 | 75 | 0.050 |
Why?
| | Observer Variation | 1 | 2024 | 314 | 0.050 |
Why?
| | Transplantation, Homologous | 4 | 2011 | 402 | 0.050 |
Why?
| | Hyperplasia | 1 | 2023 | 175 | 0.050 |
Why?
| | Breathing Exercises | 1 | 2022 | 20 | 0.050 |
Why?
| | Vocal Cords | 1 | 2022 | 32 | 0.050 |
Why?
| | Cough | 1 | 2023 | 117 | 0.050 |
Why?
| | Biofeedback, Psychology | 1 | 2022 | 35 | 0.050 |
Why?
| | Animals | 5 | 2022 | 35409 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 64 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 374 | 0.050 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 1992 | 596 | 0.040 |
Why?
| | Esophagoscopes | 1 | 2020 | 4 | 0.040 |
Why?
| | Nasal Cavity | 1 | 2021 | 51 | 0.040 |
Why?
| | Perioperative Period | 1 | 2020 | 52 | 0.040 |
Why?
| | Internationality | 1 | 2021 | 150 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2011 | 2045 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 532 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5468 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 49 | 0.040 |
Why?
| | Laryngeal Mucosa | 1 | 2019 | 8 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 75 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2020 | 103 | 0.040 |
Why?
| | Finland | 1 | 2019 | 90 | 0.040 |
Why?
| | Lung | 2 | 2023 | 3940 | 0.040 |
Why?
| | Single-Blind Method | 1 | 2019 | 271 | 0.040 |
Why?
| | Social Support | 1 | 2023 | 587 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 212 | 0.040 |
Why?
| | California | 1 | 2020 | 400 | 0.040 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 23 | 0.040 |
Why?
| | Clinical Protocols | 1 | 2020 | 254 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 374 | 0.040 |
Why?
| | Nerve Fibers | 1 | 2019 | 91 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 186 | 0.040 |
Why?
| | Electric Impedance | 1 | 2018 | 102 | 0.040 |
Why?
| | Device Removal | 1 | 2019 | 136 | 0.040 |
Why?
| | Infant, Premature | 1 | 2022 | 541 | 0.040 |
Why?
| | Emotions | 1 | 2023 | 545 | 0.040 |
Why?
| | Interdisciplinary Research | 1 | 2018 | 26 | 0.040 |
Why?
| | Anesthetics | 1 | 2018 | 75 | 0.040 |
Why?
| | Exome | 1 | 2018 | 216 | 0.030 |
Why?
| | Chickenpox Vaccine | 1 | 1997 | 71 | 0.030 |
Why?
| | Transplantation, Autologous | 3 | 1992 | 213 | 0.030 |
Why?
| | Ultrasonography, Doppler | 1 | 2017 | 118 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 426 | 0.030 |
Why?
| | Perioperative Care | 1 | 2018 | 166 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 228 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2018 | 204 | 0.030 |
Why?
| | Taste Buds | 1 | 2019 | 206 | 0.030 |
Why?
| | Survival Analysis | 2 | 2017 | 1271 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1013 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 697 | 0.030 |
Why?
| | Comorbidity | 1 | 2020 | 1551 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2021 | 508 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 484 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 647 | 0.030 |
Why?
| | Age Factors | 2 | 2014 | 3161 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 870 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 716 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 875 | 0.030 |
Why?
| | Tongue | 1 | 2015 | 78 | 0.030 |
Why?
| | Hypertrophy | 1 | 2015 | 125 | 0.030 |
Why?
| | Adolescent Behavior | 1 | 2020 | 507 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 392 | 0.030 |
Why?
| | Long-Term Care | 1 | 2015 | 92 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 592 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1690 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 577 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1282 | 0.030 |
Why?
| | Fetal Therapies | 1 | 2013 | 35 | 0.030 |
Why?
| | Thoracotomy | 1 | 2013 | 75 | 0.030 |
Why?
| | Adult | 5 | 2023 | 35634 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2017 | 371 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2780 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2062 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2724 | 0.030 |
Why?
| | Tetanus | 1 | 1992 | 25 | 0.020 |
Why?
| | Anemia, Aplastic | 1 | 1992 | 36 | 0.020 |
Why?
| | Endoscopy | 1 | 2014 | 290 | 0.020 |
Why?
| | Neoplasms | 1 | 1986 | 2454 | 0.020 |
Why?
| | Ultrasonography, Prenatal | 1 | 2013 | 276 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5444 | 0.020 |
Why?
| | Injections, Intralesional | 1 | 2011 | 33 | 0.020 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2015 | 279 | 0.020 |
Why?
| | Incidence | 1 | 2017 | 2646 | 0.020 |
Why?
| | Malleus | 1 | 2010 | 1 | 0.020 |
Why?
| | Incus | 1 | 2010 | 8 | 0.020 |
Why?
| | Inflammation | 1 | 2021 | 2748 | 0.020 |
Why?
| | Stapes | 1 | 2010 | 32 | 0.020 |
Why?
| | Graft vs Host Disease | 1 | 1992 | 240 | 0.020 |
Why?
| | Temporal Bone | 1 | 2010 | 49 | 0.020 |
Why?
| | Aerosols | 1 | 2011 | 171 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2545 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 673 | 0.020 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1992 | 279 | 0.020 |
Why?
| | Chronic Disease | 1 | 2014 | 1724 | 0.020 |
Why?
| | Graft Survival | 1 | 2011 | 514 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1092 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2011 | 1501 | 0.020 |
Why?
| | Stents | 1 | 2011 | 504 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2010 | 530 | 0.020 |
Why?
| | Ultrasonography | 1 | 2010 | 713 | 0.020 |
Why?
| | Logistic Models | 1 | 2011 | 1989 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 4935 | 0.020 |
Why?
| | Heart Atria | 1 | 1986 | 129 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5085 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2014 | 1708 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1991 | 1560 | 0.010 |
Why?
| | Pancreatic Function Tests | 1 | 1981 | 3 | 0.010 |
Why?
| | Exocrine Pancreatic Insufficiency | 1 | 1981 | 20 | 0.010 |
Why?
| | Pregnancy | 1 | 2013 | 6423 | 0.010 |
Why?
| | Somatostatin | 1 | 1980 | 56 | 0.010 |
Why?
| | Middle Aged | 3 | 2019 | 31177 | 0.010 |
Why?
| | Dietary Fats | 1 | 1980 | 303 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 1997 | 78 | 0.010 |
Why?
| | Triglycerides | 1 | 1980 | 528 | 0.010 |
Why?
| | Chickenpox | 1 | 1997 | 80 | 0.010 |
Why?
| | Immune Tolerance | 1 | 1997 | 356 | 0.010 |
Why?
| | Herpes Zoster | 1 | 1997 | 317 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 1997 | 602 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 1997 | 851 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1997 | 2016 | 0.010 |
Why?
| | Bone Marrow Purging | 1 | 1991 | 3 | 0.010 |
Why?
| | Daunorubicin | 1 | 1991 | 26 | 0.010 |
Why?
| | Thioguanine | 1 | 1991 | 18 | 0.010 |
Why?
| | Cytarabine | 1 | 1991 | 57 | 0.010 |
Why?
| | Remission Induction | 1 | 1992 | 274 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1992 | 326 | 0.010 |
Why?
| | Vaccination | 1 | 1997 | 1348 | 0.000 |
Why?
| | Combined Modality Therapy | 1 | 1991 | 1201 | 0.000 |
Why?
| | Fluoresceins | 1 | 1981 | 47 | 0.000 |
Why?
| | Lipase | 1 | 1980 | 66 | 0.000 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1980 | 160 | 0.000 |
Why?
| | Cholesterol | 1 | 1980 | 412 | 0.000 |
Why?
| | Blood Glucose | 1 | 1980 | 2103 | 0.000 |
Why?
| | Insulin | 1 | 1980 | 2330 | 0.000 |
Why?
|
|
Prager's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|